TI
BIO icon

Trexquant Investment’s Bio-Rad Laboratories Class A BIO Stock Holding History

Trexquant Investment’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,399
Closed -$3.07M – 1448
2023
Q1 		$3.07M Buy
6,399
+3,831
+149% +$1.79M 0.08% 317
2022
Q4 		$1.08M Buy
2,568
+479
+23% +$193K 0.03% 618
2022
Q3 		$871K Buy
2,089
+1,361
+187% +$679K 0.03% 580
2022
Q2 		$360K Buy
+728
New +$379K 0.02% 1024
2021
Q3 		– Sell
-1,280
Closed -$825K – 1139
2021
Q2 		$825K Sell
1,280
-1,413
-52% -$860K 0.07% 353
2021
Q1 		$1.54M Buy
+2,693
New +$1.59M 0.14% 186
2020
Q2 		– Sell
-6,604
Closed -$2.31M – 1165
2020
Q1 		$2.31M Buy
+6,604
New +$2.43M 0.17% 176
2019
Q2 		– Sell
-7,781
Closed -$2.38M – 819
2019
Q1 		$2.38M Buy
7,781
+6,483
+499% +$1.75M 0.17% 178
2018
Q4 		$301K Sell
1,298
-663
-34% -$178K 0.02% 780
2018
Q3 		$614K Buy
+1,961
New +$609K 0.05% 482
2018
Q1 		– Sell
-1,307
Closed -$312K – 1075
2017
Q4 		$312K Buy
+1,307
New +$317K 0.03% 732
2017
Q3 		– Sell
-1,362
Closed -$308K – 777
2017
Q2 		$308K Buy
+1,362
New +$297K 0.08% 451
2016
Q3 		– Sell
-4,321
Closed -$618K – 735
2016
Q2 		$618K Buy
+4,321
New +$616K 0.08% 404
2015
Q3 		– Sell
-4,200
Closed -$632K – 1043
2015
Q2 		$632K Sell
4,200
-3,300
-44% -$472K 0.07% 523
2015
Q1 		$1.01M Buy
+7,500
New +$930K 0.1% 361

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Trexquant Investment's BIO Position: Q2 2023 in Review

Trexquant Investment sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 6,399 shares — an estimated $3.07M sold.

Trexquant Investment first reported a position in BIO in Q1 2015 and held it in 15 quarters. The position peaked at $3.07M in Q1 2023. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Trexquant Investment reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Trexquant Investment sold 6,399 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $3.07M.
  • Trexquant Investment first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 15 quarters.
  • Trexquant Investment's Bio-Rad Laboratories Class A position peaked at $3.07M in Q1 2023.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.